geroprobПроблемы геронаукиProblems of Geroscience2949-47452949-4753АНО «ОСО ИТЕМ»10.37586/2949-4745-1-2023-39-50geroprob-9Research ArticleОригинальные исследованияOriginal studiesСвязь симптомов постковидного синдрома с основными клинико-лабораторными показателямиThe Relationship between Long COVID Symptoms and Clinical and Laboratory CharacteristicsМайтесянЛ. В.MaytesyanL. V.

Майтесян Лилит Варшамовна, врач- кардиолог

Maytesyan Lilit V., MD, cardiologist

ЦойИ. Р.TsoyI. R.

Цой Инна Руслановна, кардиолог, врач функциональной диагностики

Tsoy Inna R., MD, cardiologist

https://orcid.org/0000-0002-4193-688XТкачеваО. Н.TkachevaO. N.

Ткачева Ольга Николаевна, член-корреспондент РАН, д-р мед. наук, профессор, директор

Tkacheva Olga N., MD, PhD, professor, corresponding member of the Russian Academy of Sciences. Director

tkacheva@rgnkc.ruhttps://orcid.org/0000-0002-3657-0676СтражескоИ. Д.StrazheskoI. D.

Стражеско Ирина Дмитриевна, д-р мед. наук, за меститель директора по трансляционной медицине, ведущий научный сотрудник отдела возраст-ассоциированных заболеваний медицинского научно-образовательного центра МГУ им. М.В. Ломоносова.

Strazhesko Irina D., MD, PhD, professor, Deputy Director for Translational Medicine, Leading Researcher, the Department of Age-Related Diseases, Medical Scientific and Educational Center, Lomonosov Moscow State University

strazhesko_id@rgnkc.ruФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России, Российский геронтологический научно-клинический центрРоссияRussian Gerontology Research and Clinical Centre, Pirogov National Research Medical UniversityRussian Federation202311092023013950Copyright © Майтесян Л.В., Цой И.Р., Ткачева О.Н., Стражеско И.Д., 20232023Майтесян Л.В., Цой И.Р., Ткачева О.Н., Стражеско И.Д.Maytesyan L.V., Tsoy I.R., Tkacheva O.N., Strazhesko I.D.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.geronauka.com/jour/article/view/9

В настоящее время все большее количество пациентов продолжают длительно испытывать симптомы COVID-19 по окончании острого периода болезни. В связи с этим представляется важным определение факторов, связанных с развитием постковидного синдрома, и возможных способов влияния на них.Были обследованы 100 участников в возрасте 26–80 лет. Средний возраст всех участников составил 56 ± 12 лет. Наиболее частыми симптомами у пациентов, перенесших тяжелую коронавирусную пневмонию (КВП) за 3 месяца до включения, являлись усталость, одышка, нарушения сна, выпадение волос, боли в суставах, головная боль. В данной статье мы выделили возможные факторы риска развития этих симптомов

Currently, an increasing number of patients continue to experience long COVID-19 symptoms after initially contracting the SARS-CoV-2 virus. In this regard, it is important to identify the factors associated with the development of post-COVID syndrome and possible ways to influence them.We examined 100 patients aged 26–80 years. The mean age of all participants was 56 ± 12 years. Patients who had severe coronavirus pneumonia 3 months prior to enrollment experienced mainly fatigue, shortness of breath, sleep disorder, hair loss, joint pain, and headache.In this article, we described the most possible causes and risk factors for the development of post-COVID syndrome.

пандемия COVID-19SARS-CoV-2постковидный синдромфакторы риска постковидного синдромаCOVID-19 pandemicSARS-CoV-2post-COVOD syndromerisk factors for Post-COVID-19ReferencesH Crook, S Raza, J Nowell, M Young et al. (2021). Long covid— mechanisms, risk factors, and management. BMJ 2021; 374 doi: https://doi.org/10.1136/bmj.n1648 (Published 26 July 2021) Cite this as: BMJ 2021;374:n1648H Crook, S Raza, J Nowell, M Young et al. (2021). Long covid— mechanisms, risk factors, and management. BMJ 2021; 374 doi: https://doi.org/10.1136/bmj.n1648 (Published 26 July 2021) Cite this as: BMJ 2021;374:n1648Hannah E. Davis et al. Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact. 2020Hannah E. Davis et al. Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact. 2020Arnold DT, Hamilton FW, Milne A, et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up; results from a prospective UK cohort. medRxiv 2020;:2020.08.12.20173526. doi:10.1101/2020.08.12.20173526Arnold DT, Hamilton FW, Milne A, et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up; results from a prospective UK cohort. medRxiv 2020;:2020.08.12.20173526. doi:10.1101/2020.08.12.20173526Carfì A, Bernabei R, Landi F, et al. (2020): Persistent Symptoms in Patients After Acute COVID-19. JAMA 2020;324:603–5. doi:10.1001/jama.2020.12603Carfì A, Bernabei R, Landi F, et al. (2020): Persistent Symptoms in Patients After Acute COVID-19. JAMA 2020;324:603–5. doi:10.1001/jama.2020.12603Mitrani RD, Dabas N, Goldberger JJ. (2020): COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors. Heart Rhythm 2020;17:1984–90.doi:10.1016/j.hrthm.2020.06.026Mitrani RD, Dabas N, Goldberger JJ. (2020): COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors. Heart Rhythm 2020;17:1984–90.doi:10.1016/j.hrthm.2020.06.026Proal AD and VanElzakker MB (2021) Long COVID or Postacute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 12:698169. doi: 10.3389/fmicb.2021.698169Proal AD and VanElzakker MB (2021) Long COVID or Postacute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 12:698169. doi: 10.3389/fmicb.2021.698169Carfì A, Bernabei R, Landi F, Gemelli Against COVID-19 Post-Acute Care Study Group. Gemelli against C-P-ACSG. Persistent symptoms in patients after acute COVID-19. JAMA 2020;324:603-5. doi:10.1001jama.2020.12603Carfì A, Bernabei R, Landi F, Gemelli Against COVID-19 Post-Acute Care Study Group. Gemelli against C-P-ACSG. Persistent symptoms in patients after acute COVID-19. JAMA 2020;324:603-5. doi:10.1001jama.2020.12603Harry Crook, Sanara Raza, Joseph Nowell, Megan Young et al.: Long covid—mechanisms, risk factors, and management.Harry Crook, Sanara Raza, Joseph Nowell, Megan Young et al.: Long covid—mechanisms, risk factors, and management.BMJ 2021; 374 doi: https://doi.org/10.1136/bmj.n1648 (Published 26 July 2021) Cite this as: BMJ 2021;374:n1648BMJ 2021; 374 doi: https://doi.org/10.1136/bmj.n1648 (Published 26 July 2021) Cite this as: BMJ 2021;374:n1648Islam MF, Cotler J, Jason LA. Post-viral fatigue and COVID-19: lessons from past epidemics. Fatigue 2020;8:61-9. doi:10.1080/21641846.2020.1778227.Islam MF, Cotler J, Jason LA. Post-viral fatigue and COVID-19: lessons from past epidemics. Fatigue 2020;8:61-9. doi:10.1080/21641846.2020.1778227.

The authors declare that there are no conflicts of interest present.